Addressing this, Li et al. highlighted the transformative potential of the Y-shaped neuropeptide Y (NPY)-mimetic peptide-dye self-assembly system designed to cross the BBB target glioma mitochondria and enable noninvasive NIR-II fluorescence imaging for diagnosis and therapeutic monitoring. This evidence concerns the gene NPY and central nervous system cancer.